Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...

Cantor Fitzgerald analysts maintained their Overweight rating and $19.00 price target for Avita Medical Ltd . (NASDAQ:RCEL) stock, despite the shares being down nearly 50% over the past year.

Q4 2024 Earnings Call Transcript February 12, 2025 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.08, ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...

Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business. And ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a micro-cap pharmaceutical company with a market capitalization of $1.43 million focused on non-addictive pain management treatments, has ...